FONAR Co. (NASDAQ:FONR - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $16.26 and traded as low as $15.20. FONAR shares last traded at $15.34, with a volume of 8,004 shares traded.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered shares of FONAR from a "strong-buy" rating to a "buy" rating in a research note on Saturday, November 16th.
Read Our Latest Stock Report on FONR
FONAR Price Performance
The company has a fifty day moving average price of $15.47 and a two-hundred day moving average price of $16.26. The firm has a market cap of $96.06 million, a price-to-earnings ratio of 10.84 and a beta of 1.22.
Institutional Investors Weigh In On FONAR
Institutional investors and hedge funds have recently modified their holdings of the stock. Inspire Advisors LLC raised its position in shares of FONAR by 177.3% during the second quarter. Inspire Advisors LLC now owns 28,344 shares of the medical equipment provider's stock worth $454,000 after purchasing an additional 18,124 shares during the period. Renaissance Technologies LLC raised its holdings in FONAR by 11.5% during the 2nd quarter. Renaissance Technologies LLC now owns 344,216 shares of the medical equipment provider's stock worth $5,507,000 after buying an additional 35,375 shares during the period. Kayne Anderson Rudnick Investment Management LLC lifted its stake in FONAR by 1.3% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 609,789 shares of the medical equipment provider's stock valued at $9,757,000 after buying an additional 7,645 shares in the last quarter. Lakewood Asset Management LLC purchased a new position in shares of FONAR in the third quarter worth approximately $173,000. Finally, Empowered Funds LLC increased its position in shares of FONAR by 5.3% in the third quarter. Empowered Funds LLC now owns 18,690 shares of the medical equipment provider's stock worth $303,000 after acquiring an additional 938 shares in the last quarter. Institutional investors and hedge funds own 50.64% of the company's stock.
About FONAR
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
Further Reading
Before you consider FONAR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FONAR wasn't on the list.
While FONAR currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
